Optimizing the Localization Dimension of Targeted Axillary Dissection: Beyond Sentinel Node Mapping Localization in TAD
Abstract
N/A
References
Pelegrina-Perez T, Torres-Olivieri A, Rodriguez-Torres E, Rosado-Rodriguez A, Ortiz-Ocasio LS, Echenique-Gaztambide M. Indocyanine green enhancement for targeted lymph node dissection in axillary staging. Arch Breast Cancer. 2026;13(1):72-77. doi: 10.32768/abc.8042619753-148
Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: Implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072-1078. doi: 10.1200/JCO.2015.64.0094
Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455-1461. doi: 10.1001/jama.2013.278932
de Wild SR, Koppert LB, van Nijnatten TJA, Kooreman LFS, Vrancken Peeters MJTFD, Smidt ML, et al. Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: Variation in type of marker and timing of placement. Br J Surg. 2024;111(3):znae071. doi: 10.1093/bjs/znae071
Mactier M, Arthur L, Magill L, Duncan K, Mansell J, Campbell EJ, et al. De-escalation of axillary surgery and targeted axillary dissection following neoadjuvant chemotherapy: Multicentre prospective regional audit. BJS Open. 2025;10(1):zraf172. doi: 10.1093/bjsopen/zraf172
Coogan AC, Lunt LG, O'Donoghue C, Keshwani SS, Madrigrano A. Efficacy of targeted axillary dissection with radar reflector localization before neoadjuvant chemotherapy. J Surg Res. 2024;295:597-602. doi: 10.1016/j.jss.2023.11.061
Cabıoğlu N, Karanlık H, Yılmaz R, Emiroğlu S, Tükenmez M, Bademler S, et al. Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy. World J Surg Oncol. 2024;22(1):178. doi: 10.1186/s12957-024-03413-6
Winder AA, Spillane AJ, Sood S, McKessar M, Cohn D, Snook K. Radio-isotope occult lesion localization (ROLL) techniques to identify the clipped node for targeted axillary dissection (TAD) in breast cancer. ANZ J Surg. 2022;92(11):3017-3021. doi: 10.1111/ans.18079
Has Simsek D, Emiroglu S, Yilmaz R, Bayram A, Isik EG, Tukenmez M, et al. SPECT/CT lymphoscintigraphy guidance simplifies and improves targeted axillary dissection of the clipped nodes after neoadjuvant chemotherapy in initially node-positive breast cancer. Clin Nucl Med. 2022;47(11):e682-e688. doi: 10.1097/RLU.0000000000004340
Authors
Copyright (c) 2026 Archives of Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.